Richard Ellis

916 citations
21 papers · 329 indexed · h-index 9
Topics
Colorectal Cancer Treatments and Studies (6 papers)Gastric Cancer Management and Outcomes (4 papers)Multiple Sclerosis Research Studies (3 papers)

In The Last Decade

Richard Ellis

20 papers receiving 315 citations

Peers

Richard Ellis
Comparison fields: 5 of 92
  • Rheumatology 80
  • Pathology and Forensic Medicine 77
  • Oncology 67
  • Biomedical Engineering 58
  • Surgery 52
Replace AE James with:
AE James United States
K.‐J. Wolf Germany
Wilhelm Horger Germany
K.-J. Wolf Germany
Koichi Mori Japan
Osnat Dogadkin Israel
Arik Hanannel Israel
Pauline K. Chu United States
Inneke Willekens Belgium
Elena Kaye United States
Richard Ellis relative to AE James United States AE James's profile →
Citations per field
00.5×
AE James · 1×
Citations per year

Countries citing papers authored by Richard Ellis

Since Specialization
Citations

This map shows the geographic impact of Richard Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Ellis more than expected).

Fields of papers citing papers by Richard Ellis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Ellis. The network helps show where Richard Ellis may publish in the future.

Co-authorship network of co-authors of Richard Ellis

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Ellis. A scholar is included among the top collaborators of Richard Ellis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Ellis. Richard Ellis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 12
3 0
4 1
5 6
6 3
7 19
8 1
9 2
10 63
11 27
12 75
13 5
14 4
15 28
16 11
17
Antimicrobial therapy: toward the future.
3
18 2
19 41
20 1

About Richard Ellis

Richard Ellis is a scholar working on Equine, Applied Microbiology and Biotechnology and Oncology, having authored 21 papers that have together received 329 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (6 papers), Gastric Cancer Management and Outcomes (4 papers) and Multiple Sclerosis Research Studies (3 papers). The work is most often cited by research in Rheumatology (80 citations), Equine (8 citations) and Pathology and Forensic Medicine (77 citations). Richard Ellis has collaborated with scholars based in United Kingdom, Australia and France. Frequent co-authors include M. Boggild, R. Barrett, C. Peter Winlove, D.A. Bradley, P. Bleuet, M. N. Rosenbluth, R.F. Post, Karen Knapp, Lorraine Pinnington and Kenton P. Arkill. Their work appears in journals such as Physical Review Letters, Journal of Clinical Oncology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026